Confidentiality and Publication. Subject to the remaining provisions of this clause 8, each Party will treat all Confidential Information of any other Party as confidential and will not, without the consent of the other relevant Party, disclose or permit the same either to be disclosed to third parties or to be used, except solely as contemplated by this Agreement. Each Party must use all reasonable endeavours to ensure that its representatives comply with the obligations of confidentiality imposed upon it under this clause 8 as if those representatives were bound in the same way. Each Party must advise each other Party as soon as practicably possible of any breach of any confidentiality obligations under this Agreement of which it becomes aware. A Party may disclose Confidential Information if required to do so by law or to its professional advisers, subject to the relevant adviser being bound by similar obligations of confidentiality, or if necessary, entering into an appropriate confidentiality undertaking. A Party may publish the Project IP, subject to it complying with the following: prior to any publication, the Party must provide the other Party with full details of the Project IP it proposes to publish and the nature of the publication; and the other Party must notify the first Party whether permission to publish has been granted or refused within 30 days of the request (or such other period as may be set out at Item 7 of the Schedule) (Period); and if the other Party fails to notify the first Party of its decision under clause 8.5(b) within the Period shall be deemed to have consented to the proposed publication by the first Party; and any other Party may only refuse a request to publish if, in that other Party’s reasonable opinion, the publication is likely to jeopardise: the protection of Project IP (as applicable) under any statute of monopoly; or the successful commercialisation of the Project IP by the Party with such rights, or
Confidentiality and Publication. 26 5.1 CONFIDENTIALITY..............................................................................26 (a) Nondisclosure Obligation.....................................................................26 (b) Disclosure to Agents.........................................................................27 (c) Disclosure to a Third Party..................................................................27 5.2 PUBLICITY....................................................................................27 5.3 PUBLICATION..................................................................................28
Confidentiality and Publication. This Agreement shall not be interpreted to prevent or delay publication of Research findings resulting from the use of the Material or from its Modifications. The Recipient shall supply the Provider with a copy of all publication draft. The Recipient understands The Provider may forward such draft for Inserm’s review, as necessary. In accordance with scientific customs, the contributions of those who have made Material available or of collaborators, if any, from Inserm will be reflected expressly in all written or oral public disclosures concerning Research using the Material by acknowledgement or co-authorship, as appropriate. The origin of the Material and any applicable patent notices must be included in such disclosures.
Confidentiality and Publication. During the Collaboration Term and for [...***...] years thereafter, the receiving party shall not publish or otherwise disclose to a third party, other than an Affiliate, and shall not use for any purpose other than as expressly provided for in this Agreement any Information furnished to it by the other party through the end of the Collaboration Term (collectively, "Confidential Information"). For the purpose of this Section 13, the term "receiving party" with respect to Roche shall include Affiliates that agree to be bound by the terms and conditions of this Agreement. Each receiving party may use Confidential Information of the other party only to the extent required to accomplish the purposes of this Agreement. Each receiving party will use at least the same standard of care as it uses to protect proprietary or confidential information of its own to ensure that its employees, agents, consultants and other representatives do not disclose or make any unauthorized use of the other party's Confidential Information. Confidential Information shall not include information which the receiving party can prove by competent tangible evidence: (i) is now, or hereafter becomes, through no act or failure to act on the part of the receiving party, generally known or available; (ii) is known by the receiving party at the time of receiving such information, as evidenced by its tangible records; (iii) is hereafter furnished to the receiving party by a third party, as a matter of right and without restriction on disclosure; (iv) is independently discovered or developed by the receiving party without the use of Confidential Information of the disclosing party; or (v) is the subject of a written permission to disclose provided by the disclosing party. The terms of this Agreement shall be considered Confidential Information, except to the extent that the parties authorize otherwise. Notwithstanding the foregoing, (i) each Party shall have the right to disclose the material terms of this Agreement in confidence to any bona fide potential investor, investment banker, acquirer, merger partner or other potential financial partner, and where ***CONFIDENTIAL TREATMENT REQUESTED reasonably practicable, hall obtain an adequate agreement of confidentiality consistent with the terms of this Agreement, and (ii) if a Party is required to make a disclosure of this Agreement in a regulatory filing, then it will be permitted to do so, provided that it gives reasonable advance notice to the...
Confidentiality and Publication. The Recipient agrees to hold and to procure the holding in strictest confidence of the Data and Cambridge’s confidential relating to the Data(“Information”). These obligations of confidentiality do not apply to Information which: was lawfully in the Recipients possession or control prior to the date of disclosure; or was in the public domain or enters into the public domain through no improper act on the Recipient’s part or on the part of any of the Recipient’s employees; or is given to the Recipient from sources independent of Cambridge; or was independently developed by the Recipient without the knowledge of the Information provided by Cambridge as evidenced by contemporaneous written records; or must be disclosed for minimum lawful compliance with court orders, regulations or statutes. . The Recipient understands that the Data are confidential. The Recipient shall keep the Data secure at the Recipient Scientist’s laboratory and ensure that no-one other than the Recipient Scientist and the employees under the direct supervision of the Recipient Scientist who have a need to have access to the Data for the purposes of the Research Programme have access to them. These obligations of confidentiality and non-use shall survive termination of this Agreement for a period of () years. The Recipient is free to publish the results of the Research Programme provided that the Recipient shall acknowledge Cambridge and/or the Originator as the source of the Data in any publication which mentions the Data. The Recipient agrees not to disclose Cambridge’s Information without seeking permission from Cambridge prior to publishing. The Recipient shall send the Originator reprints of any publications acknowledging use of the Materials.
Confidentiality and Publication. 13 6.1. Non-Disclosure Obligations.................... 13 6.2. Release of Obligations........................ 14 6.3. Publications.................................. 14
Confidentiality and Publication. 16 8 TERMINATION .................................................20 9 GENERAL .....................................................22
Confidentiality and Publication. The Parties, including their employees, subcontractors, consultants, etc., shall observe uncondi- tional secrecy regarding the business secrets, concepts and relations of the other Party and other confidential information disclosed to the Parties in connection with the preparation, execu- tion and performance of this Agreement. Such information from the other party may solely be used, stored and processed for purposes of performance of the Agreement. Such use, storage and processing shall take place in a safe manner and with at least the same care that the party uses for its own business secrets.
Confidentiality and Publication. Confidentiality
Confidentiality and Publication. Subject to the remaining provisions of this clause 6, each Party will treat all Confidential Information of the other Party as confidential and will not, without the consent of the other Party disclose or permit the same either to be disclosed to third parties or to be used, except solely as contemplated by this Agreement. Each Party must use all reasonable endeavours to ensure that: its Representatives comply with the obligations of confidentiality imposed upon it under this clause 6 as if those Representatives were bound in the same way. Each Party must advise the other Party as soon as practicably possible of any breach of any confidentiality obligations under this Agreement of which it becomes aware. A Party may disclose Confidential Information if required to do so by law or to its professional advisers, subject to the relevant adviser entering into an appropriate confidentiality undertaking. <Lead institution> may publish the Research Results, subject to it complying with the following: prior to any publication, the <Lead institution> must provide the other Party with the Research Results it proposes to publish and the nature of the publication; and the other Party must provide their solicited contribution to <Lead institution> within 30 days of the request; and if the other Party fails to provide their solicited contribution within the said 30 days, then <Lead institution> may publish the relevant Research Results. Each Party’s obligations under this clause 6 shall survive termination or expiration of this Agreement.
